Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in IBIO — iBio, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to IBIO Full portfolio

Position in IBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$176
+$175 QoQ
Shares Held
101
+10000.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 55 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. IBIO ranks #383 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in IBIO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $176 101
2026-03-31 $1 1
2025-12-31 $1 1
2025-09-30 $3 4
2025-06-30 $1 1
2025-03-31 $4 1
2024-12-31 $2 1
2024-09-30 $2 1
2024-06-30 $2 1
2024-03-31 $113 28
2023-12-31 $16 12
2023-09-30 $43 147
2023-06-30 $68 113
2023-03-31 $207 100
2022-12-31 $36 85
2022-09-30 $348 2,049
2022-06-30 $535 2,060
2022-03-31 $55,757 129,668
2021-12-31 $66,438 120,798
2021-09-30 $876 827
2021-06-30 $5,577 3,694
2021-03-31 $103,934 67,490
2020-12-31 $312,920 298,020
2020-09-30 $340,971 167,967
2020-06-30 $267,445 120,471
2020-03-31 $983 928